| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥6.3B | ¥5.3B | +20.4% |
| Operating Income | ¥-4.5B | ¥-6.5B | +30.9% |
| Ordinary Income | ¥-4.5B | ¥-6.5B | +30.7% |
| Net Income | ¥-4.3B | ¥-5.8B | +26.2% |
| ROE | -139.9% | -69.2% | - |
FY2025 Q1 results: Revenue 6.3B yen (YoY +20.4%), Operating Income -4.5B yen (loss reduced by 30.9% from -6.5B yen prior year), Ordinary Income -4.5B yen (loss reduced by 30.7% from -6.5B yen), Net Income -4.3B yen (loss reduced by 26.2% from -5.8B yen). The company continues to operate at a loss despite solid revenue growth. The gross profit margin of 70.7% demonstrates the potential profitability of the business model, while elevated SG&A expenses of 9.0B yen (142.0% of revenue) remain the primary obstacle to achieving operating profitability. The company raised 4.1B yen through financing activities to maintain liquidity. Basic EPS improved to -65.21 yen from -98.61 yen, reflecting ongoing losses but at a reduced rate compared to the prior year.
Revenue increased 20.4% to 6.3B yen, driven by expansion in the PHR platform services business. Cost of sales rose to 1.9B yen, yielding a gross profit of 4.5B yen at a healthy 70.7% margin. However, SG&A expenses of 9.0B yen consumed 142.0% of revenue, resulting in an operating loss of 4.5B yen. This represents a significant improvement from the prior year loss of 6.5B yen, with the reduction rate of 30.9% exceeding the revenue growth rate. Non-operating income and expenses contributed negligibly to ordinary income, which stood at -4.5B yen, nearly identical to operating income. The gap between ordinary income of -4.5B yen and pre-tax income of -5.3B yen stems from extraordinary losses of 0.9B yen, primarily consisting of impairment losses of 0.9B yen. These non-recurring factors depressed net income to -4.3B yen, though the company managed to reduce the loss magnitude by 26.2% year-over-year. Minority interests contributed 0.1B yen of income, slightly offsetting the parent company loss. The performance pattern reflects "revenue up, loss reduced but still negative profitability," indicating gradual operational improvement that has not yet reached breakeven.
[Profitability] ROE of -139.9% reflects substantial net losses relative to equity base. Operating margin of -71.2% indicates high fixed cost burden relative to current revenue scale. Net profit margin of -67.4% shows large losses before returning to shareholders. Gross profit margin of 70.7% demonstrates inherent unit economics strength once scale is achieved. [Cash Quality] Cash and deposits of 7.1B yen provide 1.97x coverage of short-term liabilities. Operating cash flow of -3.3B yen represents 0.61x of net income, indicating earnings are not cash-backed. Free cash flow of -4.3B yen confirms ongoing cash consumption. [Investment Efficiency] Total asset turnover of 0.60x reflects revenue generation of 0.60 yen per yen of assets. Intangible assets of 1.0B yen and goodwill of 1.0B yen together account for 19.0% of total assets, suggesting historical M&A or development investments. [Financial Health] Equity ratio of 29.0% indicates elevated leverage. Current ratio of 244.2% demonstrates strong short-term liquidity positioning. Debt-to-equity ratio of 2.44x exceeds prudent thresholds and signals financial leverage concerns. Retained earnings deficit of -24.3B yen reflects accumulated historical losses that constrain financial flexibility.
Operating cash flow of -3.3B yen improved 45.4% from prior year but remains negative, consuming cash as the company invests in growth ahead of profitability. The operating CF to net income ratio of 0.61x indicates that less than two-thirds of the accounting loss translates to cash outflow, with non-cash items such as depreciation and amortization of 0.1B yen and impairment losses partially offsetting cash burn. Working capital changes reflected a positive impact from receivables declining by 0.4B yen and payables increasing by 0.1B yen, partially mitigating operational cash consumption. Investing cash flow of -1.1B yen was predominantly driven by intangible asset acquisitions of 1.0B yen, while capital expenditures remained minimal at 0.0B yen. Financing cash flow of 4.1B yen reflects equity capital raised during the period to shore up liquidity. Free cash flow of -4.3B yen underscores the company's ongoing reliance on external financing to fund operations and investments. Cash and deposits increased to 7.1B yen, representing 67.5% of total assets, providing a liquidity cushion against near-term obligations.
Ordinary income of -4.5B yen versus operating income of -4.5B yen shows minimal non-operating impact, confirming that core business losses are the primary driver of negative profitability. Non-operating income totaled 0.0B yen and expenses totaled 0.0B yen, reflecting negligible contributions from financial activities or equity method investments. Extraordinary losses of 0.9B yen, consisting primarily of impairment losses, widened pre-tax losses to -5.3B yen and represent non-recurring factors depressing current period results. Operating cash flow of -3.3B yen relative to net income of -4.3B yen yields a ratio of 0.61x, below the 0.8x threshold that typically signals healthy earnings quality. This suggests that a meaningful portion of accounting losses consists of non-cash charges such as depreciation and impairment, yet the company still consumes cash in operations due to working capital demands and the underlying operating loss. The combination of negative operating cash flow and accounting losses, alongside one-time impairment charges, indicates that core profitability has not been achieved and cash generation remains a future milestone contingent on revenue scale and cost management.
First, profitability achievement risk remains elevated as the company recorded an operating loss of 4.5B yen despite 20.4% revenue growth, with SG&A expenses at 9.0B yen consuming 142.0% of revenue. Until the company achieves operating leverage through revenue scale outpacing fixed costs, losses will persist and require ongoing external financing. Second, financial leverage risk is significant with a debt-to-equity ratio of 2.44x and equity ratio of only 29.0%, leaving limited cushion against downturns and increasing the cost and difficulty of future capital raises. Accumulated deficit in retained earnings of -24.3B yen further constrains financial flexibility. Third, cash burn risk is material as free cash flow of -4.3B yen and operating cash flow of -3.3B yen indicate the company is consuming cash faster than it generates from operations. With cash and deposits at 7.1B yen, the runway depends on the pace of operational improvement and potential need for additional financing within 12 to 24 months if losses continue at current rates.
[Industry Position] (Reference - Proprietary Analysis) Given the company operates in the PHR platform services market, it competes with digital health and healthcare IT providers. The company's 70.7% gross margin is in line with SaaS and platform business models that typically achieve 70-80% gross margins at scale. However, the operating margin of -71.2% and ROE of -139.9% indicate the company is in an earlier growth stage compared to mature peers that have achieved positive operating margins of 10-20% and ROE in the mid-single to low-double digits. Equity ratio of 29.0% is below typical industry medians of 40-60% for established technology and healthcare services firms, reflecting aggressive growth investment and accumulated losses. Revenue growth of 20.4% is healthy and suggests market traction, though absolute revenue scale of 6.3B yen remains modest relative to larger incumbents. The company's financial profile aligns with a pre-profitability growth-stage firm that prioritizes market expansion and platform development over near-term earnings, contrasting with profitable industry participants that balance growth and cash generation.
Revenue growth of 20.4% and a gross margin of 70.7% confirm the company is gaining market traction and possesses a high-margin business model with scalability potential once operating leverage is achieved. Operating losses narrowed by 30.9% year-over-year, outpacing revenue growth and signaling improving cost efficiency, though breakeven remains a future milestone dependent on sustained revenue expansion and disciplined SG&A management. Financial leverage of 2.44x debt-to-equity and negative free cash flow of -4.3B yen highlight ongoing reliance on external capital, with financing cash flow of 4.1B yen in the period indicating active capital raising to extend runway. Key forward-looking indicators center on the trajectory of SG&A as a percentage of revenue, the pace of operating cash flow improvement, and management's ability to achieve profitability inflection without excessive dilution or balance sheet strain. Monitoring quarterly operating cash flow trends, receivables collection efficiency with DSO at 81 days, and the cadence of intangible asset investments will be critical to assessing the company's progress toward sustainable cash generation and financial independence.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.